Priority symptoms in advanced breast cancer: Development and initial validation of the national comprehensive cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)

Value in Health

Volumn 15, Issue 1, 2012, Pages 183-190

  Garcia, Sofia F ^a   Rosenbloom, Sarah K ^a   Beaumont, Jennifer L ^a   Merkel, Douglas ^b,c   Von Roenn, Jamie H ^a   Rao, Deepa ^d   Cella, David ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

breast cancer; health related quality of life; measurement; patient centered; patient reported outcome; questionnaire development; symptom

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NATIONAL COMPREHENSIVE CANCER NETWORK FUNCTIONAL ASSESSMENT OF CANCER THERAPY BREAST CANCER SYMPTOM INDEX 16; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SYMPTOMATOLOGY; TREATMENT OUTCOME; VALIDITY; WELLBEING;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HEALTH STATUS; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM STAGING; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84856002103     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.08.1739     Document Type: Article

References (40)

1. American Cancer Society Cancer Facts & Figures 2010 2010 American Cancer Society, Inc. Atlanta, GA
2. M. Garcia, A. Jemal, E.M. Ward Global Cancer Facts & Figures 2007 American Cancer Society Atlanta, GA
3. L. Fallowfield Quality of life in breast cancer - -results from 3 cancer research campaign studies Acta Clin Belg 15 Suppl. 1993 19 23
4. K. Glanz, C. Lerman Psychosocial impact of breast cancer: a critical review Ann Behav Med 14 1992 204 212
5. A. Montazeri Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007 J Exp Clin Cancer Res 27 2008 32
6. A. Coates, V. Gebski, J.F. Bishop Improving the quality of life during chemotherapy for advanced breast cancer: a comparison of intermittent and continuous treatment strategies N Engl J Med 317 1987 1490 1495 (Pubitemid 17160543)
7. G. Vogelsang, J.R. Brahmer Patient-reported outcomes and managed care decisions: quality of life and related components Am J Manag Care 8 2002 S548 S549
8. U.S. Food and Drug Administration, Center for Drug Evaluation and Research Meeting of the Quality of Life Subcommittee of the Oncologic Drugs Advisory Committee 2000 Bethesda, MD
9. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, et al. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009 U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health Rockville, MD
10. K.M. Taylor, K.G. Macdonald, A. Bezjak Physicians' perspective on quality of life: an exploratory study of oncologists Qual Life Res 5 1996 5 14 (Pubitemid 26100497)
11. A. Bezjak, K.M. Taylor, P. Ng Quality-of-life information and clinical practice: the oncologist's perspective Cancer Prev Control 2 1998 230 235 (Pubitemid 29030235)
12. G.P. Browman Science, language, intuition, and the many meanings of quality of life J Clin Oncol 17 1999 1651 1653 (Pubitemid 29269232)
13. R.A. Deyo, D. Patrick Barriers to the use of health status measures in clinical investigation, patient care, and policy research Med Care 27 1989 S254 S267
14. T.M. Gill, A.R. Feinstein A critical appraisal of the quality of quality-of-life measurements JAMA 272 1994 619 626 (Pubitemid 24255222)
15. J. Morris, D. Perez, B. McNoe The use of quality of life data in clinical practice Qual Life Res 7 1998 85 91 (Pubitemid 28113968)
16. E.A. Rothermich, D.S. Pathak References for health-related quality-of-life claims in prescription drug advertisements Am J Health Syst Pharm 54 1997 2596 2599 (Pubitemid 27511869)
17. J. Beitz Quality-of-life end points in oncology drug trials Oncology 13 1999 1439 1442
18. N.K. Leidy, D.A. Revicki, B. Geneste Recommendations for evaluating the validity of quality of life claims for labeling and promotion Value Health 2 1999 113 126
19. C.S. Cleeland Symptom burden: multiple symptoms and their impact as patient-reported outcomes J Natl Cancer Inst Monogr 37 2007 16 21
20. G. Williams, R. Pazdur, R. Temple Assessing tumor-related signs and symptoms to support cancer drug approval J Biopharm Stat 14 2004 5 21 (Pubitemid 38294749)
21. L.J. Fallowfield Behavioural interventions and psychological aspects of care during chemotherapy Eur J Cancer 28A Suppl. 1 1992 S39 S41
22. H.J. Sutherland, G.A. Lockwood, N.F. Boyd Ratings of the importance of quality of life variables: therapeutic implications for patients with metastatic breast cancer J Clin Epidemiol 43 1990 661 666 (Pubitemid 20232520)
23. C.S. Cleeland, G.J. Bennett, R. Dantzer Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? Cancer 97 2003 2919 2925
24. C. Brunelli, M. Costantini, P. Di Giulio Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage 15 1998 151 158 (Pubitemid 28169137)
25. C. Lampic, L. von Essen, V.W. Peterson Anxiety and depression in hospitalized patients with cancer: agreement in patientstaff dyads Cancer Nurs 19 1996 419 428 (Pubitemid 26391334)
26. G. Macquart-Moulin, P. Viens, M.L. Bouscary Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care Br J Cancer 76 1997 1640 1645 (Pubitemid 27520595)
27. S.D. Passik, W. Dugan, M.V. McDonald Oncologists' recognition of depression in their patients with cancer J Clin Oncol 16 1998 1594 1600 (Pubitemid 28175786)
28. A.S. Stromgren, M. Groenvold, L. Pedersen Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating J Pain Symptom Manage 21 2001 189 196 (Pubitemid 32192936)
29. D.F. Cella, D.S. Tulsky, G. Gray The Functional Assessment of Cancer Therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579 (Pubitemid 23071057)
30. M.J. Brady, D.F. Cella, F. Mo Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument J Clin Oncol 15 1997 974 986 (Pubitemid 27106280)
31. S.X. Kong, S.K. Gandhi Methodologic assessments of quality of life measures in clinical trials Ann Pharmacother 31 1997 830 836 (Pubitemid 27332468)
32. K. Webster, D. Cella, K. Yost The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation Health Qual Life Outcomes 1 2003 79
33. D. Cella, A.E. Bonomi Measuring quality of life Oncology 9 1995 47 60
34. D. Cella, D. Paul, S. Yount What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN) Cancer Invest 21 2003 526 535 (Pubitemid 37169556)
35. K.J. Yost, S.E. Yount, D.T. Eton Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) Breast Cancer Res Treat 90 2005 295 298 (Pubitemid 40576843)
36. S.K. Rosenbloom, S.E. Yount, K.J. Yost Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: measurement compliance with regulatory demands I.V. Farquhar, K.H. Summers, A.L. Sorkin, The Value of Innovation: Impacts on Health, Life Quality, and Regulatory Research 2008 Elsevier Oxford 53 66
37. C. Zubrod, M. Schneiderman, E. Frei III Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene J Chronic Dis 11 1960 7 33
38. R. Brooks EuroQol: the current state of play Health Policy 37 1 1996 53 72 (Pubitemid 26191458)
39. G. Ryan, H.R. Bernard Data management and analysis methods N.K. Denzin, Y.S. Lincoln, Handbook of Qualitative Research 2nd ed. 2000 Sage Thousand Oaks, CA 428 444
40. D.L. Fairclough, D.F. Cella Functional Assessment of Cancer Therapy (FACT-G): non-response to individual questions Qual Life Res 5 1996 321 329 (Pubitemid 26228465)